ATAI Life Sciences NV
NASDAQ:ATAI
ATAI Life Sciences NV
Net Income (Common)
ATAI Life Sciences NV
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Net Income (Common)
-$40.2m
|
CAGR 3-Years
38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bayer AG
XETRA:BAYN
|
Net Income (Common)
-€2.9B
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Net Income (Common)
€2.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
9%
|
|
MPH Health Care AG
XETRA:93M1
|
Net Income (Common)
€29.1m
|
CAGR 3-Years
38%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Net Income (Common)
€62.4m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Net Income (Common)
€12m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is ATAI Life Sciences NV's Net Income (Common)?
Net Income (Common)
-40.2m
USD
Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Net Income (Common) amounts to -40.2m USD.
What is ATAI Life Sciences NV's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
38%
Over the last year, the Net Income (Common) growth was 74%. The average annual Net Income (Common) growth rates for ATAI Life Sciences NV have been 38% over the past three years .